Discrepant findings in immune responses to JC virus in patients receiving natalizumab.
Tan
Chen S
CS
Chen
Yiping
Y
Viscidi
Raphael P
RP
Kinkel
R Philip
RP
Stein
Marion C
MC
Koralnik
Igor J
IJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000941:Antigens / Q000378:metabolism; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016899:Interferon-beta / Q000627:therapeutic use; D007577:JC Virus / Q000378:metabolism; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology* / Q000378:metabolism; D000069442:Natalizumab; D013601:T-Lymphocytes / Q000378:metabolism
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000941:Antigens; D007155:Immunologic Factors; D000069442:Natalizumab; D016899:Interferon-beta